** Shares of investment accounting software provider Clearwater Analytics rise as much as 4.9%; last up 3.7% at $28.08
** Morgan Stanley upgrades CWAN to "overweight" from "equal-weight"; raises PT to $34 from $30, a 25.5% upside to stock's last close
** Brokerage says the acquisition of rival Enfusion is a transformation deal for co as it solidifies CWAN as a dominant software provider to the investment management industry
** Adds that it is bullish on both the underlying strategic rationale and the financial implications of the deal
** CWAN earlier this week struck a $1.5 bln cash-and-stock deal for ENFN to boost its international presence and to enter the hedge fund industry
** Nine of 10 brokerages rate the stock "buy" or higher and one "hold"; median PT $34 - data compiled by LSEG
** CWAN stock jumped 37.4% in 2024
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.